<DOC>
	<DOCNO>NCT02552589</DOCNO>
	<brief_summary>The purpose double blind study prove whether fluoride contain toothpaste able reduce dental plaque gingival inflammation patient gingivitis applied twice daily brush home period 12 week .</brief_summary>
	<brief_title>Effect Toothpaste Reduction Plaque Inflammation</brief_title>
	<detailed_description>Before study start , investigator study nurse train apply SOPs , parameter , adverse event management . On-site monitoring do sponsor recruitment , visit 2 final visit . All source data enter paper CRFs . For statistical analysis data enter data bank via double data entry . Programmed range check , validity check , consistency check , manual/visual data check medicinal plausibility do blind data review meeting . During blind data review meeting minor protocol violation record assess . No imputation miss data do ITT PP analyse . The sample size estimation carry mean one-sided unpaired t-test one-sided significance level α=0.05 . For test superiority test product negative control , investigator test hypothesis , H0 : μTest product - μNegative control ≤ 0 H1 : μTest product - μNegative control &gt; 0 use one-sided t-test α=0.05 . A relevant difference Δ=0.14 standard deviation σ=0.4 assume base previous study . When estimate drop-out rate 20 % total 120 = 102 + 18 subject per group assign study start . Drop-outs replace study . The primary parameter difference plaque index baseline ( V1 ) value value 12 week +/- 5 day ( V3 ) product use . For primary statistical analysis , t-tests ( unpaired situation ) perform one-sided significance level α=0.05 . The primary efficacy analysis perform ITT-analysis set . Secondary variable assess t-tests confidence interval compare difference V2 , V3 , baseline test product group negative control group . Descriptive statistic perform oral examination group ( count percentage score nominal ordinal scale data , least ordinal scale data minimum , maximum , median , mean value standard deviation ) . A two-sided significance level α=0.05 chosen secondary analysis , adjustment multiplicity do . Safety assessment base mainly frequency adverse event .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Gingivitis</mesh_term>
	<mesh_term>Dental Plaque</mesh_term>
	<mesh_term>Fluorophosphate</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>Male female adult ( age 18 65 year ) , Individuals gingival inflammation , mean fullmouth GI ≥ 1.2 inclusion , Individuals plaque , mean fullmouth PI ≥ 1.2 inclusion , Nonsmokers former smoker least 1 year occasional smoker maximum 5 cigarette per week , Individuals least 20 teeth exclude wisdom teeth , Subjects must read , understood sign informed consent form Willingness abstain use interdental brushing device contain antibacterial agent , like amine fluoride , chlorhexidine , silver ion etc . full course study Individuals severe systemic disease ( tumor , infectious disease ) diseases require regular systemic medication intake may affect gingival condition ( e. g. phenytoin , nifedipine , cyclosporine , antibiotic , steroid , antiphlogistics ) Individuals moderate severe chronic aggressive periodontitis ( PSI &gt; 2 2 sextant PSI &gt; 3 ) , Individuals require antibiotic treatment dental appointment ( endocarditis prophylaxis ) , Individuals treat antibiotic less 8 week prior baseline examination and/or duration trial , Individuals participate another clinical study le 4 week prior baseline examination , Individuals mucosal disease , Individuals severe oropharyngeal infection , Individuals significant dental disorder ( e.g . : caries , suspect pulp pathology , abscess , pulpitis ) , History gingival surgery previous three month , Ongoing dental treatment medical treatment oral cavity , Individuals pregnant breast feeding , Individuals history chronic drug abuse another illness allow person assess nature and/or possible consequence study , Smokers 5 cigarette per week , Individuals know hypersensitivity allergy test product ingredient , Individuals treat antibacterial mouthrinses ( e. g. chlorhexidine ) 4 week less recruitment , Individuals unwilling abstain additional oral hygiene measure treatment phase exception habitual mechanical cleaning procedure , NonCaucasians , Subjects exclude principal investigator discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>clinical trial , phase III</keyword>
	<keyword>plaque index</keyword>
	<keyword>gingivitis index</keyword>
	<keyword>fluoride</keyword>
	<keyword>toothpaste</keyword>
</DOC>